Gerald R Rhodes
Overview
Explore the profile of Gerald R Rhodes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vela J, Miller M, Rhodes G, Ray A
Antivir Ther
. 2008 Oct;
13(6):789-97.
PMID: 18839780
Background: Alterations in endogenous nucleotide pools as a result of HIV therapy with nucleoside and nucleotide reverse transcriptase inhibitors (N[t]RTIs) is a proposed mechanism for therapy-related adverse events and drug...
2.
Reiser H, Wang J, Chong L, Watkins W, Ray A, Shibata R, et al.
Clin Cancer Res
. 2008 May;
14(9):2824-32.
PMID: 18451250
Purpose: GS-9219, a novel prodrug of the nucleotide analogue 9-(2-phosphonylmethoxyethyl)guanine (PMEG), was designed as a cytotoxic agent that preferentially targets lymphoid cells. Our objective was to characterize the antiproliferative activity,...
3.
Tong L, Phan T, Robinson K, Babusis D, Strab R, Bhoopathy S, et al.
Antimicrob Agents Chemother
. 2007 Aug;
51(10):3498-504.
PMID: 17664327
Human immunodeficiency virus protease inhibitors (PIs) modestly affect the plasma pharmacokinetics of tenofovir (TFV; -15% to +37% change in exposure) following coadministration with the oral prodrug TFV disoproxil fumarate (TDF)...
4.
Cihlar T, Ray A, Laflamme G, Vela J, Tong L, Fuller M, et al.
Antivir Ther
. 2007 May;
12(2):267-72.
PMID: 17503669
Background: Active renal secretion of tenofovir (TFV) across proximal tubules occurs via uptake by human organic anion transporters 1 and 3 (hOAT1 and hOAT3) coupled with efflux by multidrug resistance...
5.
Bruno R, Olivares R, Berille J, Chaikin P, Vivier N, Hammershaimb L, et al.
Clin Cancer Res
. 2003 Mar;
9(3):1077-82.
PMID: 12631610
Purpose: To identify predictors of treatment outcome and survival in patients with non-small cell lung cancer (NSCLC) treated with docetaxel. Experimental Design: The data were collected from 180 NSCLC patients...